tiprankstipranks
Advertisement
Advertisement

PRAX Stock Latest News

Praxis Precision Medicines Readies for Pivotal FDA Decisions
Company AnnouncementsPraxis Precision Medicines Readies for Pivotal FDA Decisions
2d ago
PRAX
Praxis Precision price target raised to $575 from $470 at Goldman Sachs
PremiumThe Fly
Praxis Precision price target raised to $575 from $470 at Goldman Sachs
4d ago
PRAX
Praxis Precision price target raised to $945 from $765 at Raymond James
PremiumThe Fly
Praxis Precision price target raised to $945 from $765 at Raymond James
8d ago
PRAX
Praxis Precision price target raised to $462 from $449 at RBC Capital
PremiumThe Fly
Praxis Precision price target raised to $462 from $449 at RBC Capital
18d ago
PRAX
Praxis Precision price target raised to $514 from $400 at Baird
PremiumThe Fly
Praxis Precision price target raised to $514 from $400 at Baird
18d ago
PRAX
Praxis Precision price target raised to $362 from $323 at Wells Fargo
PremiumThe FlyPraxis Precision price target raised to $362 from $323 at Wells Fargo
18d ago
PRAX
Praxis Precision Medicines Reaffirmed With Buy Rating on FDA Progress and $1.4 Billion Cash Runway Supporting 2028 Launch Plans
Premium
Ratings
Praxis Precision Medicines Reaffirmed With Buy Rating on FDA Progress and $1.4 Billion Cash Runway Supporting 2028 Launch Plans
18d ago
PRAX
Praxis Precision reports Q2 EPS ($2.87), consensus ($3.69)
Premium
The Fly
Praxis Precision reports Q2 EPS ($2.87), consensus ($3.69)
19d ago
PRAX
Praxis Highlights Strong Q2 Update and FDA Progress
PremiumCompany Announcements
Praxis Highlights Strong Q2 Update and FDA Progress
19d ago
8K
PRAX
Praxis Extends Vormatrogine Epilepsy Trial, Keeping Long-Term Growth Story in Play
PremiumCompany Announcements
Praxis Extends Vormatrogine Epilepsy Trial, Keeping Long-Term Growth Story in Play
22d ago
PRAX
Praxis Advances PRAX-628 Tablet Formulation in Completed Bioavailability Study
PremiumCompany Announcements
Praxis Advances PRAX-628 Tablet Formulation in Completed Bioavailability Study
22d ago
PRAX
Praxis Precision initiated with a Buy at Goldman Sachs
PremiumThe Fly
Praxis Precision initiated with a Buy at Goldman Sachs
1M ago
PRAX
Praxis Precision, Remagine Labs Partner on Ulixacaltamide Patch
PremiumCompany AnnouncementsPraxis Precision, Remagine Labs Partner on Ulixacaltamide Patch
2M ago
8K
PRAX
Praxis Precision, Remagine Labs announce research collaboration and license pact
Premium
The Fly
Praxis Precision, Remagine Labs announce research collaboration and license pact
2M ago
PRAX
Raymond James Analyst Maintains Buy on Praxis, Sees PDUFA Extension as Manageable While Trimming Price Target from $731 to $719
Premium
Ratings
Raymond James Analyst Maintains Buy on Praxis, Sees PDUFA Extension as Manageable While Trimming Price Target from $731 to $719
2M ago
PRAX
FDA Extends Review Timeline for Praxis’ Relutrigine NDA
PremiumCompany Announcements
FDA Extends Review Timeline for Praxis’ Relutrigine NDA
2M ago
8K
PRAX
Praxis Precision price target raised to $575 from $510 at Needham
PremiumThe Fly
Praxis Precision price target raised to $575 from $510 at Needham
2M ago
PRAX
Praxis Wins FDA Breakthrough Status for Elsunersen Epilepsy Drug
PremiumCompany Announcements
Praxis Wins FDA Breakthrough Status for Elsunersen Epilepsy Drug
2M ago
8K
PRAX
Praxis Precision granted breakthrough therapy designation for elsunersen
PremiumThe Fly
Praxis Precision granted breakthrough therapy designation for elsunersen
2M ago
PRAX
Praxis Precision initiated with an Outperform at RBC Capital
PremiumThe FlyPraxis Precision initiated with an Outperform at RBC Capital
2M ago
PRAX
Praxis Precision Medicines Shareholders Back Directors and Governance
Premium
Company Announcements
Praxis Precision Medicines Shareholders Back Directors and Governance
2M ago
8K
PRAX
Praxis Precision management to meet with Piper Sandler
Premium
The Fly
Praxis Precision management to meet with Piper Sandler
3M ago
PRAX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >